GlassScriptPhysician profile
Jessica Ferrell
NPI 1982076956
$1,873.34
in general payments reported to CMS, 2019-2025
26 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $733 · 2022: $261 · 2023: $449 · 2024: $187 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $315.26 | 2023 | Myrisk |
| Medtronic, INC. | $272.04 | 2021-2022 | |
| Abbvie INC. | $230.21 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $159.39 | 2021-2025 | |
| Biogen, INC. | $154.02 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $143.55 | 2021-2025 | Veozah |
| Horizon Therapeutics Plc | $120.84 | 2021 | |
| Lilly USA, LLC | $43.64 | 2021-2024 | Zepbound |
| Axonics, INC. | $41.11 | 2021 | |
| Exact Sciences Corporation | $38.37 | 2024-2025 | Cologuard Collection Kit |
| Organon LLC | $35.79 | 2021-2025 | Nexplanon |
| Therapeuticsmd, INC. | $35.02 | 2021 | |
| Supernus Pharmaceuticals, INC. | $33.01 | 2022 | |
| Avanos Medical | $32.86 | 2024 | On-Q* Pump and Accessories |
| Bayer Healthcare Pharmaceuticals INC. | $25.11 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $24.89 | 2022 | |
| Evofem Biosciences, INC. | $22.19 | 2024 | |
| Rochester Medical Corporation | $20.44 | 2021 | |
| Novo Nordisk INC | $19.88 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.22 | 2025 | |
| Antares Pharma, INC. | $17.64 | 2021 | |
| Shield Therapeutics INC | $14.56 | 2024 | |
| Aspira Women'S Health INC | $14.36 | 2024 | Ova1 |
| Dexcom, INC. | $14.15 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $12.97 | 2021 | |
| Avion Pharmaceuticals | $12.82 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Ferrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.